Covid Antiviral Drug, Merck, Seeks EMERGENCY FDA Authorization

Kim Iversen and Robby Soave, discuss the future of COVID ‘miracle drug’ molnupiravir in response to news that Merck has requested emergency use authorization from the FDA.